Page last updated: 2024-08-23

etoposide and Cystadenocarcinoma, Papillary

etoposide has been researched along with Cystadenocarcinoma, Papillary in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Matsui, H; Nagai, Y; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N	1
Esfahani, JK; Gilani, MM; Moosavi, AS; Tehranian, A	1
Arai, Y; Inoue, K; Kubo, T; Nishida, M; Sasaki, J; Sato, Y	1
Fennelly, D; Gogas, H	1

Reviews

1 review(s) available for etoposide and Cystadenocarcinoma, Papillary

Article	Year
Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature. Gynecologic oncology, 1996, Volume: 63, Issue:3 Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Papillary; Dexamethasone; Etoposide; Female; Humans; Middle Aged; Neoplasm, Residual; Osteonecrosis; Ovarian Neoplasms; Paclitaxel	1996

Article

Year

Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature.

Gynecologic oncology, 1996, Volume: 63, Issue:3

Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Papillary; Dexamethasone; Etoposide; Female; Humans; Middle Aged; Neoplasm, Residual; Osteonecrosis; Ovarian Neoplasms; Paclitaxel

1996

Other Studies

3 other study(ies) available for etoposide and Cystadenocarcinoma, Papillary

Article	Year
Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer. European journal of gynaecological oncology, 2002, Volume: 23, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Japan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies	2002
Daily low-dose oral etoposide for recurrent epithelial ovarian cancer after platinum-based therapy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2004, Volume: 24, Issue:3 Topics: Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Iran; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Survival Analysis; Treatment Failure	2004
[A case of poorly differentiated ovarian serous adenocarcinoma responding favorably to etoposide and cisplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:13 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma, Papillary; Drug Administration Schedule; Etoposide; Female; Humans; Ovarian Neoplasms	1996